Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
AI-driven precision in prostate brachytherapy: A systematic review of 70 studies
0
Zitationen
6
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) has transformed prostate brachytherapy by enhancing precision, efficiency, and personalization. This systematic review evaluates 70 peer-reviewed studies from PubMed, Embase, and Web of Science, focusing on the applications of AI in imaging, treatment planning, applicator reconstruction, and outcome prediction. Machine learning (ML) and deep learning (DL) techniques, including U-Net and deep reinforcement learning, demonstrate improvements in segmentation (84% sensitivity), dose optimization (20-30% time savings), and quality assurance (25% error reduction). Challenges include limited dataset diversity, generalizability, and clinical integration. This review highlights AI's potential to revolutionize prostate brachytherapy and identifies research gaps necessary for its clinical adoption.
Ähnliche Arbeiten
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 · 5.692 Zit.
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 · 5.048 Zit.
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 · 4.529 Zit.
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
1998 · 4.484 Zit.
Screening and Prostate-Cancer Mortality in a Randomized European Study
2009 · 3.987 Zit.